Comparative Pharmacology
Head-to-head clinical analysis: DETROL versus DICYCLOMINE HYDROCHLORIDE PRESERVATIVE FREE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DETROL versus DICYCLOMINE HYDROCHLORIDE PRESERVATIVE FREE.
DETROL vs DICYCLOMINE HYDROCHLORIDE (PRESERVATIVE FREE)
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Competitive muscarinic receptor antagonist, primarily targeting M3 receptors in the bladder, reducing detrusor muscle contractions and increasing bladder capacity.
Competitive antagonist of muscarinic acetylcholine receptors (M1, M2, M3) in the gastrointestinal tract, producing antispasmodic effects by reducing smooth muscle contractions.
2 mg orally twice daily; may increase to 4 mg daily in divided doses based on response.
20 mg intramuscularly every 4-6 hours.
None Documented
None Documented
Terminal half-life 6.9 hours (range 4-10 hours) for tolterodine; 7.7 hours (range 5-13 hours) for active 5-hydroxymethyl metabolite; prolonged in hepatic impairment (up to 3-fold).
5-8 hours; may be prolonged in elderly or patients with hepatic impairment
Renal: 77% (as metabolites, <1% unchanged); Fecal: 17%; Biliary: minor.
Renal (approximately 50-80% as unchanged drug and metabolites), biliary/fecal (minor, <10%)
Category C
Category A/B
Anticholinergic
Anticholinergic